AI Drug Discovery Unicorn Insilico Medicine Jumps In Hong Kong Trading Debut
Short excerpt below. Click through to read at the original source.
After raising $293 million in the IPO, Insilico Medicine aims to become “a massive source of innovative drugs for pharma companies,” says founder Alex Zhavoronkov.